Effect of Intravenous Patient-controlled Analgesia (IV-PCA) With Fentanyl in Adults for Acute Postoperative Pain Control

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01527890

Enrollment

2000

Registered

2012-02-07

Start date

2012-02-29

Completion date

2012-10-31

Last updated

2012-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea, Vomiting

Keywords

intravenous patient-controlled analgesia, IV PCA

Brief summary

In this retrospective study, the investigators examined incidence and risk factors of postoperative nausea and vomiting (PONV) in patients with fentanyl-based intravenous patient-controlled analgesia (IV-PCA).

Interventions

DRUGFentanyl

intravenous patient-controlled analgesia

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 60 Years

Healthy volunteers

Inclusion criteria

1. Adults between 20 to 60 years old 2. Date from 1st, May 2011 to 31st, October 2011 3. Patients with fentanyl based intravenous patient-controlled analgesia for postoperative pain control

Exclusion criteria

1. Reoperation within 48 hours 2. Patients who cannot express numerical rating scale for pain due to sedation

Countries

South Korea

Contacts

Primary ContactYon Hee Shim, MD, PhD

tren125@yuhs.ac82-2-2019-3547

Backup ContactJong Bum Choi, MD

romeojb@naver.com82-2-2019-3528

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026